TY  - JOUR 
AU  - Pérez-Belmonte, Luis M.
AU  - Torres-Peña, José David
AU  - López-Carmona, María D.
AU  - Ayala-Gutiérrez, M. Mar.
AU  - Fuentes-Jiménez, Francisco
AU  - Jorge Huerta, Lucía
AU  - Alonso Muñoz, Jaime
AU  - Rubio Rivas, Manuel
AU  - Madrazo, Manel
AU  - Guzmán García, Marcos
AU  - Vicente Montes, Beatriz
AU  - Fernández Sola, Joaquim
AU  - Ena, Javier
AU  - González Ferrer, Ruth
AU  - Mella Perez, Carmen
AU  - Jorge Ripper, Carlos
AU  - Napal Lecumberri, José Javier
AU  - El Attar Acedo, Iris
AU  - Plaza Canteli, Susana
AU  - Fuente Cosío, Sara
AU  - Amorós Martínez, Francisco
AU  - Cortés Rodríguez, Begoña
AU  - Pérez-Martínez, Pablo
AU  - Ramos-Rincón, José Manuel
AU  - Gómez-Huelgas, Ricardo
PY  - 2020
UR  - http://hdl.handle.net/20.500.11940/14081
AB  - Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in...
LA  - eng
KW  - Hypoglycemic Agents
KW  - Respiration, Artificial
KW  - Coronavirus Infections
KW  - Pneumonia, Viral
KW  - Propensity Score
KW  - Metformin
KW  - Sodium-Glucose Transporter 2
KW  - Insulin
KW  - Glucose
KW  - Diabetes Mellitus, Type 2
TI  - Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
DO  - 10.1186/s12916-020-01832-2
T2  - BMC Medicine
M2  - 1
KW  - COVID-19
KW  - Diabetes
VL  - 18
ER  -